Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ana Lleo

Showing results (11-20 of 202) with videos related to

Pageof 21
Sort By:
Gastroenterology|November 13, 2018
Is Liver Injury an Affordable Risk of Immune Checkpoint Inhibitor Therapy for Cancer?Massimo Colombo, Ana Lleo
Liver International : Official Journal of the International Association for the Study of the Liver|January 2, 2023
Immune checkpoint inhibitors in malignancies after liver transplantation: Better safe or sorry?Arndt Vogel, Ana Lleo
The Lancet. Gastroenterology & Hepatology|February 16, 2024
The COSMIC-312 study: will it shape future combination therapies for advanced hepatocellular carcinoma?Anna Saborowski, Ana Lleo
Cancers|April 13, 2023
Tumor-Infiltrating B Lymphocytes: Promising Immunotherapeutic Targets for Primary Liver Cancer TreatmentGiulia Milardi, Ana Lleo
Expert Review of Clinical Immunology|August 24, 2021
Targeting the RANK/RANKL pathway in autoimmune disease and malignancy: future perspectivesAna Lleo, M Eric Gershwin
Hepatology (Baltimore, Md.)|May 4, 2021
Letter to the Editor: Are We Confident That Primary Biliary Cholangitis Liver-Related Mortality Is Higher in Males?Ana Lleo, Gideon M Hirschfield
Hepatobiliary Surgery and Nutrition|May 11, 2018
Non-alcoholic fatty liver disease, non-alcoholic steatohepatitis, metabolic syndrome and hepatocellular carcinoma-a composite scenarioLuca Viganò, Ana Lleo, Alessio Aghemo
Autoimmunity Reviews|December 7, 2011
Geoepidemiology, gender and autoimmune diseaseLuca Moroni, Ilaria Bianchi, Ana Lleo
Clinics in Liver Disease|October 21, 2022
Contemporary Epidemiology of Primary Biliary CholangitisFrancesca Colapietro, Arianna Bertazzoni, Ana Lleo
Cancers|August 13, 2020
Molecular and Immunological Characterization of Biliary Tract Cancers: A Paradigm Shift Towards a Personalized MedicineInes Malenica, Matteo Donadon, Ana Lleo
Pageof 21

Showing results (11-20 of 202) with videos related to

Sort By:
Pageof 21
Gastroenterology|November 13, 2018
Is Liver Injury an Affordable Risk of Immune Checkpoint Inhibitor Therapy for Cancer?Massimo Colombo, Ana Lleo
Liver International : Official Journal of the International Association for the Study of the Liver|January 2, 2023
Immune checkpoint inhibitors in malignancies after liver transplantation: Better safe or sorry?Arndt Vogel, Ana Lleo
The Lancet. Gastroenterology & Hepatology|February 16, 2024
The COSMIC-312 study: will it shape future combination therapies for advanced hepatocellular carcinoma?Anna Saborowski, Ana Lleo
Cancers|April 13, 2023
Tumor-Infiltrating B Lymphocytes: Promising Immunotherapeutic Targets for Primary Liver Cancer TreatmentGiulia Milardi, Ana Lleo
Expert Review of Clinical Immunology|August 24, 2021
Targeting the RANK/RANKL pathway in autoimmune disease and malignancy: future perspectivesAna Lleo, M Eric Gershwin
Hepatology (Baltimore, Md.)|May 4, 2021
Letter to the Editor: Are We Confident That Primary Biliary Cholangitis Liver-Related Mortality Is Higher in Males?Ana Lleo, Gideon M Hirschfield
Hepatobiliary Surgery and Nutrition|May 11, 2018
Non-alcoholic fatty liver disease, non-alcoholic steatohepatitis, metabolic syndrome and hepatocellular carcinoma-a composite scenarioLuca Viganò, Ana Lleo, Alessio Aghemo
Autoimmunity Reviews|December 7, 2011
Geoepidemiology, gender and autoimmune diseaseLuca Moroni, Ilaria Bianchi, Ana Lleo
Clinics in Liver Disease|October 21, 2022
Contemporary Epidemiology of Primary Biliary CholangitisFrancesca Colapietro, Arianna Bertazzoni, Ana Lleo
Cancers|August 13, 2020
Molecular and Immunological Characterization of Biliary Tract Cancers: A Paradigm Shift Towards a Personalized MedicineInes Malenica, Matteo Donadon, Ana Lleo
Pageof 21